2017
DOI: 10.1161/circoutcomes.116.003227
|View full text |Cite
|
Sign up to set email alerts
|

Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice

Abstract: Background— The implementation of Target: Stroke Phase I, the first stage of the American Heart Association’s national quality improvement initiative to accelerate door-to-needle (DTN) times, was associated with an average 15-minute reduction in DTN times. Target: Stroke phase II was launched in April 2014 with a goal of promoting further reduction in treatment times for tissue-type plasminogen activator (tPA) administration. Methods and Results— We con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

6
101
1
3

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 92 publications
(111 citation statements)
references
References 24 publications
6
101
1
3
Order By: Relevance
“…They determined that the median reduction in DNT by using all of their strategies was 20 min. 13,14 Wu et al 15 at Christchurch Hospital, New Zealand, report a similarly significant DNT reduction to our study. They implemented features of the Helsinki protocol over a 2-year period with a similarly resourced stroke team as in our study and achieved a reduction of their in-hours DNT from 87 to 34 min.…”
Section: Helsinki Model In Westmeadsupporting
confidence: 83%
See 3 more Smart Citations
“…They determined that the median reduction in DNT by using all of their strategies was 20 min. 13,14 Wu et al 15 at Christchurch Hospital, New Zealand, report a similarly significant DNT reduction to our study. They implemented features of the Helsinki protocol over a 2-year period with a similarly resourced stroke team as in our study and achieved a reduction of their in-hours DNT from 87 to 34 min.…”
Section: Helsinki Model In Westmeadsupporting
confidence: 83%
“…In the United States, the Target:Stroke initiative implemented similar processes as those reported in Helsinki. They determined that the median reduction in DNT by using all of their strategies was 20 min …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Prior to MSU program expansion in the USA, a survey of hospitals participating in the Get With The Guidelines-Stroke Target: Stroke Phase II initiative revealed that alteplase was given to only 59.3% of eligible stroke presenters within 60 min and to only 30.4% within 45 min [11]. Mobile stroke units have shown an ability to treat patients rapidly, with median alarmto-treatment times more than 20 to 30 min faster than standard hospital treatment [2][3][4].…”
Section: Discussionmentioning
confidence: 99%